Table 3.

Subgroup of patients with AP and their serum and urine NGAL levels

Category of patient (n)	Serum NGAL (ng/mL)	Urine NGAL(ng/mL)
Transient AKI at admission (4)	834.1 ± 170.3	281.9 ± 203.1
Persistent AKI at admission (6)	742.4 ± 194.3	406.6 ± 131.4
New‐onset transient AKI after admission (6)	654.5 ± 337.8	343.8 ± 123.6
New‐onset persistent AKI after admission (5)	787.4 ± 220	478.6 ± 167.4
No AKI at admission (40)	507.2 ± 234.4	215 ± 156
No new‐onset AKI after admission (29)	473.3 ± 197.8	158.2 ± 99.9

AKI, acute kidney injury; AP, acute pancreatitis; NGAL, neutrophil gelatinase‐associated lipocalin.